In recent years, an increasing number of studies have shown that the JAK-STAT pathway is involved in the development of epilepsy, and inhibition of JAK-STAT activity may lead to epilepsy treatment and further generation of new small anti-inflammatory molecules [6-8]. This evidence concerns the gene SOAT1 and epilepsy.